Hamid Hoorfar

590 total citations
20 papers, 389 citations indexed

About

Hamid Hoorfar is a scholar working on Hematology, Genetics and Computer Vision and Pattern Recognition. According to data from OpenAlex, Hamid Hoorfar has authored 20 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Genetics and 5 papers in Computer Vision and Pattern Recognition. Recurrent topics in Hamid Hoorfar's work include Hemophilia Treatment and Research (6 papers), Hemoglobinopathies and Related Disorders (5 papers) and Platelet Disorders and Treatments (4 papers). Hamid Hoorfar is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Hemoglobinopathies and Related Disorders (5 papers) and Platelet Disorders and Treatments (4 papers). Hamid Hoorfar collaborates with scholars based in Iran, United States and Saudi Arabia. Hamid Hoorfar's co-authors include Peyman Eshghi, Hassan Abolghasemi, Sirous Zeinali, Abdolreza Afrasiabi, Mohammad Hadi Radfar, Mohammad Taghi Akbari, Haleh Akhavan‐Niaki, Ali Amid, Hossein Najmabadi and Nafiseh Esmaeil and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Thrombosis and Haemostasis.

In The Last Decade

Hamid Hoorfar

18 papers receiving 367 citations

Peers

Hamid Hoorfar
Elise Schapkaitz South Africa
Ademola Samson Adewoyin Nigeria
Abhishek Purohit India
John Ayodele Olaniyi Nigeria
Jo Linssen Germany
C. E. McLaren United States
Sanne de Bruin Netherlands
Andrew Osei-Bimpong United Kingdom
Paolo Carta Italy
J Roger United States
Elise Schapkaitz South Africa
Hamid Hoorfar
Citations per year, relative to Hamid Hoorfar Hamid Hoorfar (= 1×) peers Elise Schapkaitz

Countries citing papers authored by Hamid Hoorfar

Since Specialization
Citations

This map shows the geographic impact of Hamid Hoorfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Hoorfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Hoorfar more than expected).

Fields of papers citing papers by Hamid Hoorfar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Hoorfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Hoorfar. The network helps show where Hamid Hoorfar may publish in the future.

Co-authorship network of co-authors of Hamid Hoorfar

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Hoorfar. A scholar is included among the top collaborators of Hamid Hoorfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Hoorfar. Hamid Hoorfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoorfar, Hamid, Adam C. Puché, & István Merchenthaler. (2025). Thermal image edge detection for AI-powered medical research imaging. The Journal of Supercomputing. 81(4).
2.
Hoorfar, Hamid, István Merchenthaler, & Adam C. Puché. (2024). Optimizing U-Net CNN performance: a comparative study of noise filtering techniques for enhanced thermal image analysis. The Journal of Supercomputing. 80(16). 23384–23406. 4 indexed citations
3.
4.
5.
Khoury, Zaid H., Mohamed Elgharib, Mamoon M. Saeed, et al.. (2023). Generative Adversarial Networks in Digital Histopathology: Current Applications, Limitations, Ethical Considerations, and Future Directions. Modern Pathology. 37(1). 100369–100369. 19 indexed citations
6.
Hoorfar, Hamid, et al.. (2023). Efficiently Guiding K-Robots Along Pathways with Minimal Turns. 2. 7 indexed citations
7.
Hoorfar, Hamid, et al.. (2023). Securing Pathways with Orthogonal Robots. 43. 592–599. 4 indexed citations
8.
9.
Lissitchkov, Toshko, Bella Madan, Claudia Djambas Khayat, et al.. (2019). Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients. Journal of Thrombosis and Haemostasis. 18(4). 815–824. 25 indexed citations
10.
Abolghasemi, Hassan, Yunes Panahi, Gholamreza Toogeh, et al.. (2018). Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients. Journal of pharmacopuncture. 21(2). 76–81. 2 indexed citations
11.
Eshghi, Peyman, Ali Amin Asnafi, Ahmad Reza Shamshiri, et al.. (2017). The Comparison of Efficacy of Original Brand Deferoxamine with Generic Iranian Made Deferoxamine in Urinary Iron Excretion in Patients with Thalassemia Major. 9(4). 108–111. 1 indexed citations
12.
Golestani, Mina, Peyman Eshghi, Hamid Reza Rasekh, et al.. (2016). Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran.. PubMed. 15(2). 669–77. 5 indexed citations
13.
Faranoush, Mohammad, Hassan Abolghasemi, Gholamreza Toogeh, et al.. (2014). A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency. Clinical and Applied Thrombosis/Hemostasis. 21(8). 724–728. 9 indexed citations
14.
Faranoush, Mohammad, Gholamreza Toogeh, Mehran Karimi, et al.. (2014). A Comparison of Efficacy Between Recombinant Activated Factor VII (ARYOSEVEN TM) and NOVOSEVEN® in Patients with Hereditary FVIII Deficiency with Inhibitor. Blood. 124(21). 4299–4299. 1 indexed citations
15.
Faranoush, Mohammad, Hassan Abolghasemi, Fereidoun Mahboudi, et al.. (2014). A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor. Clinical and Applied Thrombosis/Hemostasis. 22(2). 184–190. 14 indexed citations
16.
17.
Moayedi, Behjat, et al.. (2012). A randomized double‐blind, placebo‐controlled study of therapeutic effects of silymarin in β‐thalassemia major patients receiving desferrioxamine. European Journal Of Haematology. 90(3). 202–209. 47 indexed citations
18.
Eshghi, Peyman, et al.. (2011). Efficacy and safety of Iranian made Deferasirox (Osveral®) in Iranian major thalassemic patients with transfusional iron overload: A one year prospective multicentric open-label non-comparative study.. PubMed. 19(3). 240–8. 6 indexed citations
19.
Hoorfar, Hamid, et al.. (2008). Evaluation of Iron Status by Serum Ferritin Level in Iranian Carriers of Beta Thalassemia Minor. International Journal for Vitamin and Nutrition Research. 78(45). 204–207. 11 indexed citations
20.
Abolghasemi, Hassan, Ali Amid, Sirous Zeinali, et al.. (2007). Thalassemia in Iran. Journal of Pediatric Hematology/Oncology. 29(4). 233–238. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elise Schapkaitz Breakdown of academic impact, for papers by Ademola Samson Adewoyin Breakdown of academic impact, for papers by Abhishek Purohit Breakdown of academic impact, for papers by John Ayodele Olaniyi Breakdown of academic impact, for papers by Jo Linssen Breakdown of academic impact, for papers by C. E. McLaren Breakdown of academic impact, for papers by Sanne de Bruin Breakdown of academic impact, for papers by Andrew Osei-Bimpong Breakdown of academic impact, for papers by Paolo Carta Breakdown of academic impact, for papers by J Roger
Rankless by CCL
2026